Background & Aims Helicobacter pylori infection is increasingly difficult to treat. The purpose
of these consensus statements is to provide a review of the literature and specific, updated …

With few exceptions, the most commonly recommended triple Helicobacter pylori regimen
(proton pump inhibitor (PPI), amoxicillin and clarithromycin) now provides unacceptably low …

Important progress has been made in the management of Helicobacter pylori infection and
in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role …

Background The optimal duration for Helicobacter pylori (H. pylori) eradication therapy is
controversial, with recommendations ranging from 7 to 14 days. Several systematic reviews …

Background As with any other infectious disease, we should aim for treatments offering≥
90% Helicobacter pylori eradication rates in clinical practice. Aim To summarize optimization …

Background: The success rate of currently recommended 7‐day triple therapy with a PPI
plus amoxicillin and clarithromycin has fallen into the unacceptable range. It is urgent to look …

Significant progress has been obtained since the III Brazilian Consensus Conference on H.
pylori infection held in 2012, in Bento Gonçalves, Brazil, and justify a fourth meeting to …

Antibiotic resistance in Helicobacter pylori is the major cause of eradication failure. Primary
H. pylori susceptibility patterns, however, are becoming less predictable. Currently, high (≥ …

Background: The eradication rate of first‐line Helicobacter pylori treatment is only 70–85%
and has been decreasing due to the increase in antibiotic resistance. The aim of this study …

The efficacy of triple therapy for Helicobacter pylori infection has dramatically declined over
the last decade, largely related to increasing clarithromycin resistance rates. From a …